Canada’s Alimentation Couche-Tard (ACT) is exploring a potential sale of its U.S. stores to ease regulatory concerns as it pursues a $47 billion acquisition of Japan’s Seven & i Holdings, the parent company of 7-Eleven.
A Couche-Tard spokesperson confirmed discussions with third parties, emphasizing a “clear path” to regulatory approval and a strong proposal to Seven & i. The move aims to facilitate the deal amid expected scrutiny from authorities.
Seven & i, in response, appointed its first foreign CEO, Stephen Dacus, who faces the challenge of restructuring the company to counter ACT’s takeover attempt. While Dacus acknowledged ongoing talks with Couche-Tard, he highlighted significant regulatory hurdles in merging the two retail giants.
Couche-Tard, which operates Circle K convenience stores worldwide, is seeking strategic measures to secure approval and expand its global presence. If successful, the acquisition would reshape the convenience store industry, creating one of the largest retail networks.
The outcome of the negotiations remains uncertain as Seven & i evaluates its options under its new leadership.


Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 



